Poster Presentations Session V
Poster Presentations Session V Wednesday, May 20, 2015
POSTERS SET-UP: 8:15 AM - 8:30 AM
POSTERS DISPLAY HOURS: 8:30 AM - 2:45 PM
POSTER AUTHOR DISCUSSION: 12:45 PM - 1:45 PM
POSTERS DISMANTLE: 2:45 PM


Poster display locations are shown below the poster codes
HEALTH SERVICES - Clinical Outcomes Studies
PHS1
A1
MEDICATION UTILIZATION IN INCIDENT ADVERSE DRUG REACTIONS OF CANCER CHEMOTHERAPY - A PHARMACIST PERSPECTIVE
Guntupalli L
chalapathi institute of pharmaceutical sciences, guntur, AA, India

PHS2
A2
SENTINEL SITE ACTIVE SURVEILLANCE OF THE SAFETY OF FIRST-LINE ANTIRETROVIRAL MEDICINES IN NAMIBIA
Mann M1, Mengistu A2, Gaeseb J3, Sagwa E4, Mazibuko G4, Garrison LP1, Stergachis A1
1University of Washington, Seattle, WA, USA, 2Therapeutics Information and Pharmacovigilance Centre Namibia, Windhoek, Namibia, 3Ministry of Health and Social Services Namibia, Windhoek, Namibia, 4Management Sciences for Health, Windhoek, Namibia

PHS3
A3
CACHEXIA & DEBILITY IN HOSPITALIZED CHILDREN WITH COMPLEX CHRONIC CONDITIONS
Van Doren BA1, Roy D1, Noone J2, Blanchette CM2, Arthur S2
1University of North Carolina, Charlotte, Charlotte, NC, USA, 2University of North Carolina at Charlotte, Charlotte, NC, USA

PHS4
A4
PATIENT AND HOSPITAL-LEVEL FACTORS ASSOCIATED WITH INPATIENT MORTALITY OF STROKE PATIENTS
Sharma M, Ferries EA, Yucel A, Johnson ML, Aparasu R
University of Houston, Houston, TX, USA

PHS5
A5
CONTEXTUAL ANALYSIS OF DETERMINANTS OF LATE DIAGNOSIS OF HEPATITIS C VIRUS INFECTION IN MEDICARE PATIENTS
Chirikov VV1, Shaya FT1, Howell CD2
1University of Maryland School of Pharmacy, Baltimore, MD, USA, 2Howard University College of Medicine, Washington, MD, USA

PHS6
A6
RISKS OF FRACTURES IN VITILIGO PATIENTS TREATED WITH PHOTOTHERAPY
Li C1, Lo P2, Huang W2, Wen Y3, Tsai Y2, Tsai T4
1National Taiwan University College of Medicine, Taipei, Taiwan, 2National Yang Ming University, Taipei, Taiwan, 3Chang Gung University, Taoyuan, Taiwan, 4National Taiwan University Hospital, Taipei, Taiwan

PHS7
A7
REMOTE MONITORING STRATEGIES FOR PATIENTS WITH STABLE HEART FAILURE: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
Pandor A, Gomersall T, Stevens JW, Wong R
The University of Sheffield, Sheffield, UK

PHS8
A8
PERFORMANCE OF TWO WORLD HEALTH ORGANIZATION DENGUE CLASSIFICATIONS IN A PEDIATRIC COHORT FROM COLOMBIA
Pinzón-Redondo H1, Paternina-Caicedo A2, Alvis-Guzman N2, Diaz-Quijano F3, Zarate-Vergara A4, Barrios-Redondo K4, De la Hoz-Restrepo F5
1Hospital Infatil Napoleón Franco Pareja, Cartagena., Colombia, 2Universidad de Cartagena, Centro de Investigación y Docencia, Hospital Infantil Napoleón Franco Pareja, Cartagena de Indias, Colombia, 3Universidad de Sao Pablo. Depatamento de Salud Pública, Sao Pablo, Brazil, 4Hospital Infatil Napoleón Franco Pareja, Cartagena, Colombia., Colombia, 5Instituto Nacional de Salud, BOGOTA D.C., Colombia

PHS9
A9
IS PHARMACEUTICAL CARE EFFECTIVE FOR IMPROVING BLOOD PRESSURE CONTROL AND MEDICATION ADHERENCE AMONG HYPERTENSIVE PATIENTS? A REVIEW
Eziyi A, Adunlin G
Florida A & M University, Tallahassee, FL, USA

PHS10
A10
EFFECTS OF SOCIAL NETWORKS ON PATIENT ADHERENCE TO PRESCRIBED TREATMENT FOR SERIOUS MENTAL ILLNESS: A SYSTEMATIC REVIEW
LyttleNguessan CJ, Campbell ES
Florida A&M University, Tallahasse, FL, USA

PHS11
A11
WITHDRAWN

PHS12
A12
COMPARISON OF THE IMPACT OF HUMAN VERSUS ANALOGUE INSULINS ON GLYCOSYLATED HEMOGLOBIN IN A POPULATION WITH DIABETES MELLITUS COLOMBIA
Machado J, Medina D
Universidad Tecnológica de Pereira, Pereira, Colombia

PHS13
A13
MANAGEMENT OF TUBEROUS SCLEROSIS COMPLEX IN ENGLAND: INSIGHTS INTO REAL-WORLD CLINICAL PRACTICE
Kingswood C1, Dew R2, Gray E3
1(On behalf of the TSC clinic network) The Royal Sussex County Hospital, Brighton, UK, 2pH Associates Ltd, Marlow, UK, 3Novartis Pharmaceuticals UK Ltd, Frimley, UK

PHS14
A14
PREDICTORS OF CIGARETTE SMOKING IN THREE ASIAN COUNTRIES: CHINA INDIA AND TAIWAN
Almogbel Y, Abughosh S, Essien EJ, Sansgiry SS
University of Houston, Houston, TX, USA

PHS15
A15
ASSESSMENT OF AWARENESS REGARDING HEPATITIS B AMONG WOMEN IN ABBOTTABAD, KPK PAKISTAN
Azhar SA1, Hassali AA2, Sana SS1, Faiza FI1, Zainab ZB1, Sundas SA1, Mahrukh MA1, Noman NH3, Fahad FS2, Izhar IH1
1COMSATS Institute of Information Technology, Abbottabad, Pakistan, 2Universiti Sains Malaysia, Penang, Malaysia, 3University of Balochistan, Quetta, Pakistan

PHS16
A16
PREVALENCE AND BURDEN OF ALPHA-1 ANTITRYPSIN DEFICIENCY AMONG HOSPITALIZED COPD PATIENTS IN THE US
Blanchette CM1, Noone J1, Roy D2, Van Doren BA1, Zacherle E1, Howden R1
1University of North Carolina at Charlotte, Charlotte, NC, USA, 2University of North Carolina, Charlotte, Charlotte, NC, USA

PHS17
A17
WITHDRAWN

PHS18
A18
PREVALENCE AND BURDEN OF ANKLE INJURIES IN NORTH CAROLINA EMERGENCY DEPARTMENTS
Shah S, Blanchette CM, Noone J, Wikstrom EA
University of North Carolina at Charlotte, Charlotte, NC, USA

PHS19
A19
NATIONAL TRENDS AND CHARACTERISTICS OF PSYCHIATRIC ADMISSIONS IN US EMERGENCY DEPARTMENTS: 2006-2011
Vohra R, Madhavan SS, Sambamoorthi U
West Virginia University, Morgantown, WV, USA

PHS20
A20
BURDEN OF DISEASE OF HEPATITIS C IN COLOMBIA
Alvis-Guzman N1, Romero M2, De la Hoz-Restrepo F3
1Universidad de Cartagena, Centro de Investigación y Docencia, Hospital Infantil Napoleón Franco Pareja, Cartagena de Indias, Colombia, 2Fundación Salutia, Bogotá D.C., Colombia, 3INSTITUTO NACIONAL DE SALUD, Bogotá, Colombia

PHS21
A21
EXAMINING RISK FACTORS AND PREDICTING READMISSIONS IN COPD PATIENTS
Sickler A, Wang QC, Chawla R, Nigam S
Independence Blue Cross, Philadelphia, PA, USA

PHS22
B1
TREATMENT FOR SUBSTANCE USE AND IMPLICATIONS FOR MORTALITY IN ELDERLY PROSTATE CANCER PATIENTS
Chhatre S, Malkowicz SB, Metzger DS, Jayadevappa R
University of Pennsylvania, Philadelphia, PA, USA

PHS23
B2
RELATION BETWEEN HEALTH INSURANCE COVERAGE AND OUTCOMES AMONG WOMEN WITH BREAST CANCER IN FLORIDA
Tawk RH1, Ali A2, Adunlin G2, Xiao H2
1Florida A&M University, Tallahassee, FL, USA, 2Florida A & M University, Tallahassee, FL, USA

HEALTH SERVICES - Cost Studies
PHS24
B3
PERIPHERAL ARTERIAL DISEASE MANAGEMENT PROGRAM: SCREENING-RISK FACTOR MANAGEMENT PROGRAM AND FINANCIAL RETURN ON INVESTMENT
Luque A1, Junqueira Junior SM2, Cabra HA3, Andrade PC2, Oliveira FM1
1Johnson & Johnson Medical Brazil, São Paulo, Brazil, 2Johnson&Johnson Medical Brazil, Sao Paulo, Brazil, 3Johnson & Johnson Medical, Mexico, D.F., Mexico

PHS25
B4
ECONOMIC BURDEN OF ADVERSE EVENTS ASSOCIATED WITH FIRST LINE METASTATIC RENAL CELL CARCINOMA (MRCC) TREATMENT IN PUBLIC AND PRIVATE BRAZILIAN PERSPECTIVE
Ferreira CN1, Santana CF2, Rufino CS1
1Pfizer Brasil, São Paulo, Brazil, 2Pfizer, São Paulo, Brazil

PHS26
B5
IMPACT OF NON-MEDICAL SWITCHING ON HEALTHCARE COSTS: A CLAIMS DATABASE ANALYSIS
Liu Y1, Skup M2, Lin J3, Chao J2
1University of Missouri–Kansas City, Kansas City, MO, USA, 2AbbVie Inc., North Chicago, IL, USA, 3Novosys Health, Green Brook, NJ, USA

PHS27
B6
INCREASED HEALTHCARE UTILIZATION ASSOCIATED WITH OBESITY
Hoshen MB, Balicer R
Clalit Health Services, Tel Aviv, Israel

PHS28
B7
COST OF IMPLEMENTING A PEDIATRIC NEUROCRITICAL CARE CENTER
Buchanan P1, Howard S1, Zhang Z1, Buelt C1, Pearson L1, Huetsch M1, Gill J2, Pineda J2
1Saint Louis University, Saint Louis, MO, USA, 2Washington University, Saint Louis, MO, USA

PHS29
B8
DIFFERENCES IN THE TOTAL HEALTHCARE COSTS DURING THE YEAR OF DIAGNOSIS BETWEEN APPALACHIAN AND A NATIONAL COHORT OF ELDERLY WOMEN WITH BREAST CANCER: AN APPLICATION OF DECOMPOSITION TECHNIQUE
Vyas A1, Madhavan SS2, Sambamoorthi U2, Pan X3, Regier M2, Hazard H2
1Rutgers University, Piscataway, NJ, USA, 2West Virginia University, Morgantown, WV, USA, 3Evidera LLC, Lexington, MA, USA

PHS30
B9
ASSESSING THE FULL BURDEN OF CARE FOR AGITATION IN PATIENTS WITH SCHIZOPHRENIA AND BIPOLAR I DISORDER
Margolis MK1, Bapat B2, Blume S1, Cicero S3, Gandhi SK3
1Evidera, Bethesda, MD, USA, 2Evidera, Lexington, MA, USA, 3TEVA Pharmaceuticals, Frazer, PA, USA

PHS31
B10
COMMON REASONS FOR AND ASSOCIATED COSTS OF PEDIATRIC INPATIENT ADMISSIONS IN THE UNITED STATES
Meyers J, Candrilli S
RTI Health Solutions, Research Triangle Park, NC, USA

PHS32
WITHDRAWN

PHS33
B11
DIRECT MEDICAL COST OF COMPLICATIONS IN PATIENTS WITH NON VALVULAR ATRIAL FIBRILLATION NVAF AT A PRIVATE HOSPITAL IN VENEZUELA
Fernandez Y1, Chiquinquira K2, Garrido Lecca S3
1Universidad Central de Venezuela Facultad de Medicina Escuela de Salud Publica, Caracas, Venezuela, 2Unesar Clinica Santa Sofía, Caracas, Venezuela, 3Bristol-Myers Squibb, Lima, Peru

PHS34
B12
DIRECT COSTS OF HEALTHCARE OF MULTIPLE SCLEROSIS, THE CASE OF A HEALTH MANTEINANCE ORGANIZATION IN COLOMBIA
Muñoz-Galindo IM1, Moreno JA1, Guarin NE1, Diaz JA2, Arevalo HO1
1Salud Total EPS, Bogotá D.C., Colombia, 2Universidad Nacional de Colombia, Bogotá D.C., Colombia

PHS35
B13
INCREMENTAL BURDEN OF GROUP 3 PULMONARY HYPERTENSION PATIENTS TO U.S. PAYER
Heresi GA1, Joish VN2, Platt D3, Abad M4, Kamalakar R3, Teal S4, Satler C3
1Department of Pulmonary and Critical Care Medicine, Cleveland, OH, USA, 2Bayer Healthcare Pharmaceuticals, Whippany, NJ, USA, 3BAYER HEALTHCARE PHARMACEUTICALS, WHIPPANY, NJ, USA, 4Bayer Pharma AG, Berlin, Germany

PHS36
B14
HOSPITALIZATION COSTS DUE TO SEVERE ACUTE RESPIRATORY INFECTION (SARI) IN THREE CENTRAL AMERICAN COUNTRIES
Alvis-Guzmán N1, Marin-Correa C2, Castañeda-Orjuela C2, Sanchez-Ruiz C3, Carrasquilla-Sotomayor M4, Sanchez F5, Mena R6, Mejía H7
1Universidad de Cartagena. Centro de Investigación y Docencia. Hospital Infantil Napoleón Franco Pareja, Cartagena de Indias, Colombia, 2Instituto Nacional de Salud, BOGOTA D.C., Colombia, 3TEPHINET, Bogota D.C., Colombia, 4Universidad de Cartagena, Centro de Investigación y Docencia, Hospital Infantil Napoleón Franco Pareja, Cartagena de Indias, Colombia, 5Universidad Autonoma de Nicaragua, Managua, Nicaragua, 6Hospital General San Juan de Dios, San Lucas Sacatepequez, Guatemala, 7Secretaría de Salud, Tegucigalpa, Honduras

PHS37
B15
RACIAL VARIATION IN THE CLINICAL AND ECONOMIC BURDEN OF SKELETAL-RELATED EVENTS AMONG ELDERLY MEN WITH STAGE IV METASTATIC PROSTATE CANCER
Jayasekera J1, Onukwugha E1, Bikov K1, Hussain A2
1University of Maryland School of Pharmacy, Baltimore, MD, USA, 2University of Maryland School of Medicine, Baltimore, MD, USA

PHS38
B16
COST OF COLORECTAL CANCER IN VIETNAM
Nguyen T, Phan T, Nguyen TT
University of Medicine and Pharmacy in HCMC, Ho Chi Minh City, Vietnam

PHS39
B17
DIRECT MEDICAL COSTS ASSOCIATED WITH CLINICAL AND HEALTH CHARACTERISTICS IN VISUALLY IMPAIRED INDIVIDUALS IN SINGAPORE
Luo N1, Wang X1, Finkelstein EA2, Lamoureux E3, Aung T4, Wong TY4, Ang M4
1National University of Singapore, Singapore, Singapore, 2Duke-NUS Graduate Medical School, Singapore, Singapore, 3Duke, Singapore, Singapore, 4Singapore National Eye Center, Singapore, Singapore

PHS40
B18
ECONOMIC BURDEN OF VACCINE-PREVENTABLE DISEASES AMONG THE ELDERLY IN TAIWAN
Lu W1, Yang HK2, Chen L3, Hsiao F1
1National Taiwan University, Taipei, Taiwan, 2Merck & Co., Inc., West Point, PA, USA, 3Taipei Veterans General Hospital, Taipei, Taiwan

PHS41
B19
DIRECT COSTS OF HEALTH CARE FOR BREAST CANCER, THE CASE OF A HEALTH MANTEINANCE ORGANIZATION IN COLOMBIA
Moreno JA1, Muñoz-Galindo IM1, Guarin NE1, Diaz JA2, Arevalo HO1
1Salud Total EPS, Bogotá D.C., Colombia, 2Universidad Nacional de Colombia, Bogotá D.C., Colombia

PHS42
B20
CLINICAL AND ECONOMIC ANALYSIS OF SIMPLE CONTACT DERMATITIS DUE TO URINARY INCONTINENCE AND PRESSURE ULCERS OF IMMOBILIZED PATIENTS WITH URINARY INCONTINENCE
Vorobiev A, Vorobiev P, Krasnova L
Russian Society for Pharmacoeconomics and Outcomes Research, Moscow, Russia

PHS43
B21
ECONOMIC BURDEN OF COLORECTAL CANCER IN VIETNAM: FROM HEALTHCARE PAYERS' PERSPECTIVE
Phan T, Hoang B, Nguyen TT
University of Medicine and Pharmacy in HCMC, Ho Chi Minh City, Vietnam

PHS44
C1
MEDICAL CARE COSTS OF CHIKUNGUNYA VIRUS INFECTION IN A PEDIATRIC POPULATION IN COLOMBIA
Castañeda-Orjuela C1, Díaz-Jiménez D1, Rodríguez-Castillo L1, Paternina-Caicedo A2, Pinzón-Redondo H3, Alvis-Guzman N2, De la Hoz-Restrepo F1
1Instituto Nacional de Salud, BOGOTA D.C., Colombia, 2Universidad de Cartagena, Centro de Investigación y Docencia, Hospital Infantil Napoleón Franco Pareja, Cartagena de Indias, Colombia, 3Hospital Infatil Napoleón Franco Pareja, Cartagena., Colombia

PHS45
C2
DIRECT COST OF HYPOTHYROIDISM AND ITS COMPLICATIONS IN UKRAINE
Vadziuk I
Ivan Horbachevsky Ternopil State Medical University, Ternopil, Ukraine

PHS46
C3
CLINICAL AND ECONOMIC IMPACT OF THE INTRODUCTION OF THE VACCINE AGAINST MENINGOCOCCAL MENINGITIS C IN CHILDREN AGED 0-4 YEARS IN BRAZIL
Andrade TR, Sansone D, Etto H, Decimoni TC, Araujo GT, Fonseca M
AxiaBio, São Paulo, Brazil

PHS47
C4
PATIENT RECALL FOLLOWING BREAST CANCER SCREENING MAMMOGRAPHY AMONG MEDICAID PATIENTS BY PATIENT RACE
Bonafede MM1, Miller JD1, Huang A2, Troeger KA3, Fajardo L4
1Truven Health Analytics, Cambridge, MA, USA, 2Truven Health Analytics, Bethesda, MD, USA, 3Hologic, Inc., Marlborough, MA, USA, 4University of Iowa, Iowa City, IA, USA

PHS48
C5
DIRECT AND INDIRECT COSTS TO EMPLOYERS OF RECALL FOLLOWING SCREENING MAMMOGRAPHY AMONG FEMALE EMPLOYEES IN THE US
Bonafede MM1, Miller JD1, Huang A2, Troeger KA3, Fajardo L4
1Truven Health Analytics, Cambridge, MA, USA, 2Truven Health Analytics, Bethesda, MD, USA, 3Hologic, Inc., Marlborough, MA, USA, 4University of Iowa, Iowa City, IA, USA

PHS49
C6
NOVEL APPROACH TO CATEGORIZING COSTS OF PATIENTS EXPERIENCING SEIZURES
Williams DV, Wix DA
Milliman, Windsor, CT, USA

PHS50
C7
ESTIMATING THE COST OF PNEUMONIA CASES ADMITTED AT THE INTERNAL MEDICINE WARDS OF A TERTIARY GOVERNMENT HOSPITAL IN THE PHILIPPINES
Rivera AS
University of the Philippines Manila, Manila, Philippines

PHS51
C8
DIRECT COSTS COMPARISON OF MEDICAL CARE BEFORE AND AFTER HEART FAILURE HOSPITALIZATION IN A MEDICARE POPULATION
Kilgore M1, Patel H2, Sharma P1, Maya J2, Kielhorn A2
1Univeristy of Alabama at Birmingham, Birmingham, AL, USA, 2Amgen, Thousand Oaks, CA, USA

PHS52
C9
COST OF A PHARMACIST-LED PNEUMONIA EDUCATION AND IMMUNIZATION PROGRAM FOR OLDER PHILADELPHIANS
Alcusky MJ, Cannon-Dang E, Steele D, Schafer JJ, DeSimone Jr. JA, Pizzi LT
Thomas Jefferson University, Philadelphia, PA, USA

PHS53
WITHDRAWN

PHS54
C10
AN ACCESSIBLE APPROACH TO ESTIMATE THE DIRECT MEDICAL COSTS OF TYPE 2 DIABETES MELLITUS FOR THE BRAZILIAN NATIONAL HEALTH SYSTEM
Aquino CM1, Lima RC2, Marinho MG3, Sousa IM3, Cesse EÂ3, Bezerra AF2
1Federal University of Pernambuco, Recife, Brazil, 2Federal University of Pernambuco, RECIFE, Brazil, 3Oswaldo Cruz Foundation - Fiocruz, Recife, Brazil

PHS55
C11
COST ANALYSIS OF PATIENTS WITH ACUTE CORONARY EVENT IN A COMMERCIAL INSURANCE COMPANY IN COLOMBIA —SALUDCOOP— IN 2013
Romero M1, Torres A2, Grosso G3, Urrutia C3
1Salutia Foundation, Bogota, Colombia, 2Salutia´s Foundation- Research center in economy, management and health technologies., Bogota, Colombia, 3Group SaludCoop, Bogotá, Colombia

PHS56
C12
WITHDRAWN

PHS57
WITHDRAWN

PHS58
WITHDRAWN

PHS59
C13
COST OF REPORTING POSSIBLE ADVERSE DRUG REACTIONS IN MEDICAL OUTPATIENTS USING A TELEPHONIC INTERACTIVE VOICE RESPONSE SYSTEM
Mahida SR1, Seoane E1, Klinger E2, Salazar A2, HER QL2, Medoff J2, Amato M1, Dykes PC2, Haas J2, Bates D2, Schiff G2
1Massachusetts College of Pharmacy and Health Sciences, Boston, MA, USA, 2Brigham and Women's Hospital, Boston, MA, USA

PHS60
C14
COST OF CANCER TREATMENT IN BRAZIL AND ITS DETERMINANTS: 2000-2003
Cherchiglia ML1, Perelman J2, Pereira J2
1Federal University of Minas Gerais, Belo Horizonte, Brazil, 2Universidade NOVA de Lisboa, Lisboa, Portugal

PHS61
C15
USING BIG DATA FOR AN ECONOMIC EVALUATION OF REDUCING THE INNAPPROPRIATE PRESCRIBING OF ATYPICAL ANTIPSYCHOTICS AMONG DEMENTIA PATIENTS
Khan R, Jammali-Blasi A, Todkar A, Heaney A
NPS MedicineWise, Sydney, Australia

PHS62
C16
COST-EFFECTIVENESS OF A BEHAVIORAL PSYCHOSOCIAL TREATMENT INTEGRATED ACROSS HOME AND SCHOOL FOR PEDIATRIC ADHD-INATTENTIVE TYPE
Tran JL, Sheng R, Esonwune-Chukwudi P, Beaulieu A, McBurnett K, Pfiffner LJ, Wilson L
University of California, San Francisco, San Francisco, CA, USA

PHS63
D1
ECONOMIC EVALUATION OF A RANDOMIZED CONTROLLED TRIAL OF PHARMACIST-SUPERVIZED PATIENT SELF-TESTING OF WARFARIN THERAPY
Gallagher J
University College Cork, Cork, Ireland

PHS64
D2
COST-EFFECTIVENESS OF BREAST CANCER SCREENING IN THE NATIONAL BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM IN THE UNITED STATES
Ekwueme D1, Hoerger T2, Miller J3, Allaire B2, Subramanian S4, Sabatino S3, Royalty J3, Li C3
1Centers for Disease Control and Prevention, Chamblee, GA, USA, 2RTI International, Research Triangle Park, NC, USA, 3US Centers for Disease Control and Prevention, Chamblee, GA, USA, 4RTI International, Waltham, MA, USA

PHS65
D3
COST EFFECTIVENESS OF GROUP-BASED PARENTING PROGRAMS AND BIBLIOTHERAPY FOR PARENTS OF CHILDREN AT RISK OF DEVELOPING CONDUCT DISORDER: A MULTICENTER RANDOMIZED CONTROLLED TRIAL
Sampaio F1, Enebrink P2, Mihalopoulos C3, Feldman I1
1Uppsala University, Uppsala, Sweden, 2Karolinska Institute, Stockholm, Sweden, 3Deakin University, Melbourne, Australia

PHS66
D4
COST-UTILITY ASSESSMENT OF HEMODIALYSIS VERSUS DIALYSIS PERITONEAL, AS TREATMENT INITIAL MODALITY IN BRAZIL: A POPULATION BASE STUDY
Cherchiglia ML1, Alvares J2, Almeida AM1, Andrade EI1, Acurcio Fa2, Andrade MV1, Szuster DA1, Guerra Jr AA1, Queiroz OV1, Gomes IC1, Puig-Junoy J3
1Federal University of Minas Gerais, Belo Horizonte, Brazil, 2College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil, 3Pompeu Fabra University, Barcelona, Spain

PHS67
D5
OUT-OF-POCKET MEDICAL COSTS FOR PARENTS WITH CHILDREN WITH DOWN SYNDROME IN THE UNITED STATES
Kageleiry A1, Samuelson D2, Duh MS2, Lefebvre P3, DerSarkissian M4, Campbell JY5, Skotko BG6
1Analysis Group, Inc., Boston, MA, USA, 2Analysis Group, Boston, MA, USA, 3Groupe d'analyse, ltée, Montreal, QC, Canada, 4Analysis Group, Los Angeles, CA, USA, 5Harvard University, Cambridge, MA, USA, 6Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

PHS68
D6
EXPECTED COSTS AND HEALTH OUTCOMES FOR A COHORT OF ALBERTANS DIAGNOSED WITH HEPATITIS C
Thanh NX1, Jacobs P1, Waye A1, Tyrrell DL2, Misurski D3
1Institute of Health Economics, Edmonton, AB, Canada, 2University of Alberta, Edmonton, AB, Canada, 3Abbvie, Chicago, IL, USA

PHS69
D7
ESTIMATING HEALTHCARE RESOURCE USE ASSOCIATED WITH THE TREATMENT OF METASTATIC MELANOMA IN EIGHT COUNTRIES
McKendrick J1, Gijsen M2, Quinn C3, Zhao Z4, Barber BL4
1PRMA Consulting, Hampshire, UK, 2PRMA Consulting, Fleet, UK, 3PRMA Consulting, Fleet Hampshire, UK, 4Amgen Inc, Thousand Oaks, CA, USA

PHS70
D8
ASSOCIATION OF CHANGE IN FORCED VITAL CAPACITY WITH HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH NEWLY DIAGNOSED IDIOPATHIC PULMONARY FIBROSIS
Reichmann WM1, Yu Y2, Macaulay D3, Nathan SD4
1Analysis Group, Inc., Boston, MA, USA, 2Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA, 3Analysis Group, Inc., New York, MA, USA, 4Inova Heart and Vascular Institute, Falls Church, VA, USA

PHS71
D9
BURDEN OF MELANOMA AMONG ADULTS ENROLLED IN MEDICAID PROGRAM
Shah R, Khanna R, Pace P, Banahan III B
University of Mississippi, University, MS, USA

PHS72
D10
EXPANSION OF CURRENT HPV VACCINATION GUIDELINES TO INCLUDE MEN WHO HAVE SEX WITH MEN WHO ARE 27 YEARS OR OLDER – A VALUE OF INFORMATION ANALYSIS
Deshmukh AA1, Cantor SB1, Fenwick E2, Chiao EY3, Nyitray AG4, Das P1, Chhatwal J1
1The University of Texas MD Anderson Cancer Center, Houston, TX, USA, 2ICON Clinical Research, Oxford, UK, 3Baylor College of Medicine, Houston, TX, USA, 4The University of Texas School of Public Health, Houston, TX, USA

HEALTH SERVICES - Patient-Reported Outcomes & Patient Preference Studies
PHS73
D11
IMPACT OF EMAIL REFILL REMINDERS ON MEDICATION ADHERENCE AMONG PATIENTS WITH CHRONIC DISEASES IN A RETAIL COMMUNITY PHARMACY
Taitel MS, Mu Y, Lou Y, Cannon A
Walgreen Co., Deerfield, IL, USA

PHS74
D12
IMPACT OF APPOINTMENT-BASED MEDICATION SYNCHRONIZATION ON EXISTING USERS OF CHRONIC MEDICATIONS
Holdford DA, Saxena K
Virginia Commonwealth University, Richmond, VA, USA

PHS75
D13
EXAMINING THE IMPACT OF A HYBRID CLINICAL PHARMACY PRACTICE MODEL ON MEDICATION ADHERENCE IN PATIENTS WITH METABOLIC SYNDROME
Pinto S, Hastings TJ, Bechtol R, Vaidya V, Khuder S
University of Toledo, Toledo, OH, USA

PHS76
D14
THREE METHODS TO ASSESS ADHERENCE TO HIV ANTIRETROVIRAL TREATMENT IN A CHILEAN HEALTHCARE SETTING
San Martin B1, Lopez M2, Cordova P2, Fernandez P2, Morales F2, Villa L2
1Hospital Chiloe, Chiloe, Chile, 2Facultad de Farmacia, Universidad de Concepción, Concepción, Chile

PHS77
D15
PHARMACOTHERAPY OPTIMIZATION PLAN FOR PATIENTS WITH TYPE-2 DIABETES MELLITUS (T2DM) AND HYPERTENSION IN A CHILEAN HEALTHCARE SETTING: IMPACT AND OUTCOMES
Soto A1, Avila X2, Cordova P3, Fernandez P3, Lopez M3, Villa LA3, Morales F3
1CESFAM Bicentenario, Arauco, Chile, 2San Vicente Hospital, Arauco, Chile, 3Facultad de Farmacia, Universidad de Concepción, Concepción, Chile

PHS78
D16
DEVELOPMENT AND VALIDATION OF PATIENT DECISION AID ýREGARDING ANTIDEPRESSANT MEDICATIONS.ý
al Jumah kA1, Hassali AA2
1MOH, riyadh, Saudi Arabia, 2Universiti Sains Malaysia, Penang, Malaysia

PHS79
E1
IMPACT OF STRUCTURED PATIENT EDUCATION ON QUALITY OF LIFE OF SOUTH INDIAN DIABETICS
Talla V1, Yellu NR2, Pippalla SR3, Rao V1, Pattnaik S1, Subudhi S4, Budike R1, Pandalaneni A3
1Talla Padmavathi College of Pharmacy, Warangal, INDIA, WARANGAL, India, 2UNIVERSITY COLLEGE OF PHARMACEUTICAL SCIENCES, KAKATIYA UNIVERSITY, WARANGAL, India, 3TALLA PADMAVATHI COLLEGE OF PHARMACY, WARANGAL, India, 4Talla Padmavathi Pharmacy College, Warangal, WARANGAL, India

PHS80
E2
A VISION ‘BOLT-ON' ITEM INCREASED THE SENSITIVITY OF EQ-5D IN A CROSS-SECTIONAL HEALTH SURVEY
Wang X1, Ang M2, Finkelstein EA3, Aung T2, Wong TY2, Lamoureux E3, Luo N4
1National University of Singapore, Singapore, Singapore, 2Singapore National Eye Center, Singapore, Singapore, 3Duke-NUS Graduate Medical School, Singapore, Singapore, 4Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore

PHS81
E3
LEAN WORKFLOW CHANGES MAY CONTRIBUTE TO IMPROVED PRIMARY CARE PATIENT SATISFACTION
Chen P, Wong E, Hung D
Palo Alto Medical Foundation, Mountain View, CA, USA

PHS82
E4
DESCRIPTION OF PATIENTS SATISFACTION OR DISSATISFACTION WITH REFERRAL AND COUNTER REFERRAL PROCESS
Mogere DM, Loum CS, Kaseje D
Great Lakes University of Kisumu, Nairobi, Kenya

PHS83
E5
TUBERCULOLIS SCREENING PREFERENCES OF HEALTHCARE WORKERS IN SOUTH AFRICA: A BEST-WORST SCALING STUDY TO ANALYZE VARIATION BY OCCUPATION
O'Hara NN1, Roy L1, O'Hara LM1, Spiegel JM1, Lynd LD1, FitzGerald JM1, Yassi A1, Nophale LE2, Marra CA3
1University of British Columbia, Vancouver, BC, Canada, 2University of the Free State, Bloemfontein, South Africa, 3Memorial University, St. John's, NF, Canada

PHS84
E6
SHARED DECISION MAKING DOES NOT IMPROVE ADHERENCE TO PROSTATE CANCER SCREENING: EVIDENCE FROM THE HEALTH INFORMATION NATIONAL TREND SURVEY
Haider MR1, Qureshi Z1, Horner R1, Bennett C2, Khan MM3
1University of South Carolina, Columbia, SC, USA, 2University of South Carolina College of Pharmacy, Columbia, SC, USA, 3University of South Carolina, COLUMBIA, SC, USA

PHS85
E7
HEALTH RELATED QUALITY OF LIFE AND HEALTH CARE RESOURCE USE BURDEN IN MIGRAINE WITH AND WITHOUT NAUSEA
Flores NM1, Lee LK1, Gajria K2, Pomerantz D3, Gandhi SK2
1Kantar Health, Foster City, CA, USA, 2Teva Pharmaceuticals Inc, Malvern, PA, USA, 3Kantar Health, Horsham, PA, USA

PHS86
E8
DO DEPRESSION RATES DIFFER BY CONFLICT ERA AMONG WAR VETERANS?
Adjei Boakye E, Stringer LR, Geneus C, Tobo BB, Buchanan P
Saint Louis University, Saint Louis, MO, USA

PHS87
E9
PATIENT REPORTED OUTCOMES REVEAL DISCORDANCE BETWEEN PATIENT AND PHYSICIAN ASSESSMENT OF DISEASE BURDEN IN PATIENTS WITH RHEUMATOID ARTHRITIS
Feinberg BA1, Lal L2, Mujumdar U1, Olson T3, Baraf HS4, Matsumoto AK4
1Cardinal Health, Dublin, OH, USA, 2Cardinal Health, Missouri City, TX, USA, 3Cardinal Health, Minneapolis, MN, USA, 4Arthritis and Rheumatism Associates, Wheaton, MD, USA

PHS88
E10
FEASIBILITY OF REAL-TIME COLLECTION OF PATIENT REPORTED OUTCOMES AT POINT OF CARE
Feinberg BA1, Baraf HS2, Matsumoto AK2, Olson T3, Mujumdar U1
1Cardinal Health, Dublin, OH, USA, 2Arthritis and Rheumatism Associates, Wheaton, MD, USA, 3Cardinal Health, Minneapolis, MN, USA

PHS89
E11
IMPACT OF PATIENT REPORTED OUTCOMES ON MEDICATION THERAPY MANAGEMENT FOR HIGH-COST SPECIALTY DRUGS
Feinberg BA1, Burruss R2, Traurig T2, Drenning J3
1Cardinal Health, Dublin, OH, USA, 2OncoSource Rx, Columbia, MD, USA, 3Cardinal Health, Dallas, TX, USA

PHS90
E12
GEOGRAPHIC PATTERNS OF SELF-REPORTED LIFETIME DEPRESSION DIAGNOSIS
Tobo BB, Adjei Boakye E, Buchanan P
Saint Louis University, Saint Louis, MO, USA

PHS91
E13
[EVALUATION OF THE QUALITY OF LIFE OF DIABETIC PATIENTS IN MINAS GERAIS STATE, BRAZIL]
Mata AR1, Ferreira Ha1, Alvares J1, Silva MR1, Araujo VE1, Diniz LM2, Acurcio Fa1
1College of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil, 2Medical College, Federal University of Minas Gerais, Belo Horizonte, Brazil

HEALTH SERVICES - Health Care Use & Policy Studies
PHS92
E14
PREDICTORS OF MAMMOGRAPHY SCREENING AMONG WOMEN AGED 50-74
Nduaguba O, Sudhapalli P, Barner J
The University of Texas at Austin, Austin, TX, USA

PHS93
E15
DISCUSSION BETWEEN PROVIDERS AND PATIENTS ABOUT PROSTATE SPECIFIC ANTIGEN TESTING IN USA
Mukherjee K1, Segal R2
1Chicago State University, Chicago, IL, USA, 2University of Florida, Gainesville, IL, USA

PHS94
E16
LONG-TERM IMPACT OF A PHARMACIST-LED DIABETES MEDICATION MANAGEMENT PROGRAM ON GLYCEMIC CONTROL
Tran M1, Godley P2, Stock EM3, Rascati KL4, Tabor PA2
1Scott & White Health Plan, Austin, TX, USA, 2Scott & White Health Plan, Temple, TX, USA, 3Center for Applied Health Research - Central Texas Veterans Health Care System jointly with Baylor Scott & White Health, Temple, TX, USA, 4The University of Texas at Austin, College of Pharmacy, Austin, TX, USA

PHS95
F1
ASSESSING A PHYSICIAN VISIT FOR HEPATIC DYSFUNCTION BASED ON DATABASE MERGING CLAIMS AND ANNUAL HEALTH CHECKUP DATA IN JAPAN
Ito C1, Nishikino R1, Onishi Y2
1Japan Medical Data Center Co.,Ltd., Tokyo, Japan, 2Creativ-Ceutical K.K., Tokyo, Japan

PHS96
F2
RELATIVE AGE IN CLASS AND ADHD IN SCHOOL CHILDREN – DIAGNOSIS AND MEDICATION PATTERNS – INTRA-ANNUAL AND INTER-ANNUAL DISPARITY
Hoshen MB1, Benis A2, Keyes KM3, Zoega H4
1Clalit Research Institute, Tel Aviv, Israel, 2Clalit Health Services, Tel Aviv, Israel, 3Columbia University, New York, NY, USA, 4Univesity of Iceland, Reykjavík, Iceland

PHS97
F3
SPECIALTY PHARMACY MEDICATION COMPLIANCE AND PERSISTENCE PROGRAM FOR PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
D'Albini L1, Tian Y2, Raspa S3, Drake W3
1Accredo, Spring Hill, KS, USA, 2Express Scripts, St. Louis, MO, USA, 3Actelion Pharmaceuticals, Inc., South San Francisco, CA, USA

PHS98
F4
DO PHARMACISTS' BARRIERS—INCLUDING NON-REIMBURSEMENT FOR NON-DISPENSING SERVICES—INFLUENCE THE LEVEL OF ADHERENCE PROMOTION ACTIVITIES FOR PERSONS LIVING WITH HIV?
Kibicho J
University of Wisconsin-Milwaukee, Milwaukee, WI, USA

PHS99
F5
REGISTRY ADOPTED AS PUBLIC POLICY FOR PROPER RISK MANAGEMENT IN CHRONIC KIDNEY DISEASE IN COLOMBIA
Acuna L, Sanchez P, Soler L
cuenta de alto costo, bogota, Colombia

PHS100
WITHDRAWN

PHS101
F6
HEALTHCARE RESOURCE USE AMONG PATIENTS WITH CONGESTIVE HEART FAILURE IN A LARGE HEALTH ORGANIZATION
Bash LD1, Weitzman D2, Sharon O3, Aviram-Paz M4, Chodick G5, Shalev V2
1Merck and Co., Inc., Rahway, NJ, USA, 2Maccabitech, Maccabi Health Care Services and Tel Aviv University, Tel Aviv, Israel, 3MSD Israel, Hod Hasharon, Israel, 4Tel Aviv University, Tel Aviv, Israel, 5Maccabi Healthcare Services and Tel Aviv University, Tel Aviv, Israel

PHS102
F7
WILL U.S. PAYERS CHAMPION BIOSIMILARS?
Malik AN, Cox J, Keeping K
Decision Resources Group, London, UK

PHS103
F8
ARE GENERIC MEDICINES GOOD FOR MY PATIENTS? FINDINGS FROM A QUALITATIVE ASSESSMENT OF PERCEPTIONS AMONG MEDICAL SPECIALISTS IN MALAYSIA
Zhi Yen W1, Hassali MA2, Alrasheedy AA3, Saleem F4, Mohamad Yahaya AH1, Aljadhey H5
1Hospital Teluk Intan, Teluk Intan, Perak, Malaysia, 2Universiti Sains Malaysia (USM), Pulau Pinang, Malaysia, 3Qassim University, Almulyda, Saudi Arabia, 4Universiti Sains Malaysia, Penang, Malaysia, 5King Saud University, Riyadh, Saudi Arabia

PHS104
F9
PROTON PUMP INHIBITOR PRESCRIBING TREND IN THE US AMBULATORY SETTING
Rane P1, Aparasu RR1, Guha S2
1University of Houston, Houston, TX, USA, 2University of Texas Health Science Center, Houston, TX, USA

PHS105
F10
IMPORTANCE OF JOINT WORK BETWEEN PHARMACIST AND PHYSICIAN IN THE RATIONAL DRUG USE IN PATIENTS WITH OSTEOPOROSIS,
Estrada JI1, Galvis MJ2, Caro M3, Abad JM1, Segura AM4
1CES University, Medellin, Colombia, 2Nacional University, Bogota, Colombia, 3Antioquia University, Bogota, Colombia, 4Antioquia University, Medellin, Colombia

PHS106
F11
WITHDRAWN

PHS107
F12
PREVALENCE AND DETERMINANTS OF LOW-COST GENERIC DRUG PROGRAM USE IN THE PRIVATELY-INSURED ADULT POPULATION
Pauly N, Brown J
University of Kentucky, Lexington, KY, USA

PHS108
F13
SOCIOECONOMIC DIFFERENTIAL IN ONE-YEAR SURVIVAL AFTER HOSPITALIZATION FOR ISCHEMIC STROKE: THE EFFECT OF ACUTE AND POST-ACUTE CARE-PATHWAYS IN LAZIO REGION, ITALY
Belleudi V, Sciattella P, Agabiti N, Di Martino M, Di Domenicantonio R, Davoli M, Fusco D
Department of Epidemiology of the Regional Health Service - Lazio, ROME, Italy

PHS109
F14
GENDER DISTRIBUTION OF OUTPATIENT CARE PHYSIOTHERAPY SERVICES FOR LOW BACK PAIN IN HUNGARY
Járomi M1, Hanzel A1, Rátgéber L2, Juhász K3, Sebestyén A1, Boncz I1, Csákvári T4, Vajda R1, Molics B1
1University of Pécs, Pécs, Hungary, 2Ratgeber Academia, Pécs, Hungary, 3National Health Insurance Fund Administration, Pécs, Hungary, 4University of Pécs, Zalaegerszeg, Hungary

PHS110
F15
WITHDRAWN

PHS111
F16
FREQUENT EMERGENCY DEPARTMENT USE AMONG NON-ELDERLY ADULTS: ANALYSIS OF MULTI-STATE MEDICAID CLAIMS DATA
Agarwal P1, Bias T1, Frisbee S1, Sambamoorthi N2, Bose S1, Madhavan SS1, Sambamoorthi U1
1West Virginia University, Morgantown, WV, USA, 2Northwestern University, Chicago, IL, USA

PHS112
G1
HUMAN PAPILLOMAVIRUS (HPV) VACCINATION DURING WELL-CHILD VISITS IN PRIVATELY INSURED MALES 9-21 YEARS OF AGE IN THE UNITED STATES IN 2012
Zhang D1, Huang M2, Kulkarni AS3, Niccolai LM4
1Merck & Co., Inc., West Point, PA, USA, 2Merck & Co. Inc (under contract with Agile-1), West Point, PA, USA, 3Merck & Co. Inc, Rahway, NJ, USA, 4Yale School of Public Health, New Haven, CT, USA

PHS113
WITHDRAWN

PHS114
G2
AGE AND GENDER DISTRIBUTION OF OUTPATIENT CARE PHYSIOTHERAPY SERVICES FOR SHOULDER AND UPPER ARM INJURIES IN HUNGARY
Molics B1, Boncz I1, Endrei D1, Rátgéber L2, Juhász K3, Sebestyén A3, Vajda R1, Csákvári T4, Járomi M1
1University of Pécs, Pécs, Hungary, 2Ratgeber Academia, Pécs, Hungary, 3National Health Insurance Fund Administration, Pécs, Hungary, 4University of Pécs, Zalaegerszeg, Hungary

PHS115
G3
HEALTHCARE COVERAGE, EXPENDITURES AND POPULATION HABITS IN ARGENTINA
Najun Dubos L, Cuberos M, Benitez J
Roche Argentina, Buenos Aires, Argentina

PHS116
G4
THE IMPACT OF NCMS POLICIES ON INPATIENT HEALTH EXPENDITURE AND ITS EQUALITY IN RURAL CHINA
Guo N1, Wang J2, Shi LW3, Han S3, Zhu D4, Guan XD3
1Department of Pharmaceutical Science,Peking University, Beijing, China, 2Shandong University, Jinan, China, 3International Research Center of Medical Administration, Peking University, Beijing, China, 4Center for Health Policy and Management, Institute of Medical Information & Library, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

PHS117
G5
REDUCING MATERNAL AND CHILD MORTALITY IN GHANA: IS NATIONAL HEALTH INSURANCE SCHEME'S FREE MATERNAL CARE PROGRAMME HELPING?
Nsiah-Boateng E
National Health Insurance Authority, Accra, Ghana

PHS118
G6
DEFINITION OF END-OF-LIFE PERIOD AND QUALITY BENCHMARKS IN TERMINAL CANCER CARE: A LITERATURE REVIEW
Sieluk J1, Goto D1, Hanna N2, Mullins CD1
1University of Maryland School of Pharmacy, Baltimore, MD, USA, 2University of Maryland Department of Surgery, Division of General and Oncologic Surgery, Baltimore, MD, USA

PHS119
G7
THE IMPACT OF PATIENT CENTERED MEDICAL HOME IN A MANAGED MEDICAID POPULATION
Chu L
University of Southern California, Los Angeles, CA, USA

PHS120
G8
PREVENTING CERVIX-UTERUS CANCER IN ARGENTINA. STRUCTRURE, ORGANIZATION AND RESULTS
Maceira D
Center for the Study of State and Society (CEDES), Buenos Aires, Argentina

PHS121
G9
A NOVEL STILLBIRTH AUDIT TOOL IMPLEMENTATION IN GHANA: ASSESSMENT OF DEPLOYMENT IN 2014
Davies-Teye BB1, Baison HM2, Oduro-Mensah E3, Vanotoo L2
1Drifney Consult Ltd, Accra, Ghana, 2Greater Accra Regional Health Directorate Ghana Health Services, Accra, Ghana, 3Ridge Hospital OPD, Accra, Ghana

PHS122
WITHDRAWN

PHS123
G10
DIFFERENCES IN BREAST CANCER SCREENING RATES IN MEDICARE ADVANTAGE NON-DUAL ELIGIBLE MEMBERS, DUAL ELIGIBLES ENROLLED IN SPECIAL NEED PLANS AND OTHER HEALTHCARE PLANS
Pulungan Z, Teigland C, Mehta S, Parente A
Inovalon, Bowie, MD, USA

PHS124
G11
DIFFERENCES IN CHARACTERISTICS, HEALTH SERVICE UTILIZATION AND COST BETWEEN OLDER HOSPITALIZED LUNG CANCER PATIENTS WITH OR WITHOUT ASTHMA
Roy D1, Blanchette CM2, Zacherle E2
1University of North Carolina, Charlotte, Charlotte, NC, USA, 2University of North Carolina at Charlotte, Charlotte, NC, USA

PHS125
G12
POTENTIAL SAVINGS IN HEALTHCARE SPENDING ON “LOW-VALUE” INTERVENTIONS: CASE STUDY OF ARTHROSCOPIC KNEE SURGERY
Rane PB1, Olchanski N1, Saret CJ1, Cohen JT1, Neumann PJ2
1Center for the Evaluation of Value and Risk in Health,Tufts Medical Center, Boston, MA, USA, 2Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies,Tufts Medical Center, Boston, MA, USA

PHS126
G13
IS VISUAL IMPAIREMENT ASSOCIATED WITH INCREASED HOSPITALIZATION? A RETROSPECTIVE COHORT STUDY OF COMMUNITY-DWELLING MEDICARE BENEFICIARES
Tsang Y, Tom S, Onukwugha E
University of Maryland School of Pharmacy, Baltimore, MD, USA

PHS127
G14
HEALTH SERVICES UTILIZATION AND COSTS AMONG EMPLOYED ADULTS WITH DEPRESSION
Gangan N, Yang Y
University of Mississippi, University, MS, USA

PHS128
G15
MEDICAL RESOURCE UTILIZATION OF ACUTE MYOCARDIAL INFARCTION PATIENTS WITH READMISSION: A RETROSPECTIVE ANALYSIS OF HOSPITALIZATION DATA FROM BEIJING MEDICAL INSURANCE DATABASE
Wen L1, Wu J2, Yang L1
1Peking University, Beijing, China, 2Bayer, Beijing, China

PHS129
G16
EFFECTS OF OVERWEIGHT AND OBESITY ON HEALTH SERVICE USE AND EXPENDITURES AMONG U.S. ADULTS WITH CHRONIC RENAL DISEASE
Zanwar P1, Franzini L2
1University of Houston Clear Lake, Houston, TX, USA, 2University of Maryland School of Public Health, College Park,, MD, USA

PHS130
G17
PREDICTING MEDICAL REIMBURSEMENT AMOUNT - WHAT FACTORS DRIVE THE MEDICAL COST TREND
Wang QC, Sickler A, Chawla R, Nigam S
Independence Blue Cross, Philadelphia, PA, USA

PHS131
G18
OUT-OF-POCKET HEALTHCARE EXPENDITURES AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Kang HA, Barner JC
The University of Texas at Austin, Austin, TX, USA

PHS132
G19
COST STUDY ON PROVINCIAL GENERAL HOSPITALS
Gantugs Y1, Otgonbayar D2, Tsolmongerel T3
1Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia, 2Mongolian Medical Education Association, Ulaanbaatar, Mongolia, 3MOH, Ulaanbaatar, Mongolia

PHS133
G20
MEDICAL RESOURCE UTILIZATION OF ISCHEMIC STROKE PATIENTS WITH READMISSION: A RETROSPECTIVE ANALYSIS OF HOSPITALIZATION DATA FROM BEIJING MEDICAL INSURANCE DATABASE
Wen L1, Wu J2, Yang L1
1Peking University, Beijing, China, 2Bayer, Beijing, China

PHS134
G21
THE MARKET FOR HEPATITIS C SERVICES IN ALBERTA
Thanh NX1, Misurski D2, Waye A1, Jacobs P1, Tyrrell DL3
1Institute of Health Economics, Edmonton, AB, Canada, 2Abbvie, Chicago, IL, USA, 3University of Alberta, Edmonton, AB, Canada

PHS135
H1
COST OF PRIMARY AND SECONDARY HEALTHCARE UTILIZATION FOR PATIENTS WITH IRRITABLE BOWEL SYNDROME CALCULATED USING ROUTINELY COLLECTED ELECTRONIC RECORDS TO ASSESS THE IMPACT OF SECONDARY CARE REFERRAL
Canavan C, Card T, West J
University of Nottingham, Nottingham, UK

PHS136
H2
UTILIZATION AND PAYMENT OF ERCP-RELATED OPERATIONS AND MEDICAL SUPPLIES IN CHINA BMI INPATIENTS
Cui B1, Wang L2, Xiong X2, Li J2
1Peking University, Beijing, China, 2China Health Insurance Research Association, Beijing, China

PHS137
WITHDRAWN

PHS138
H3
COLORECTAL CANCER (CRC) COSTS IN THE US: FINDINGS FROM THE MEDICAL EXPENDITURE PANEL SURVEY 2008-2012
Haider MR1, Qureshi Z1, Horner R1, Xirasagar S1, Khan MM2
1University of South Carolina, Columbia, SC, USA, 2University of South Carolina, COLUMBIA, SC, USA

PHS139
H4
PREDICTORS AND TRENDS IN UTILIZATION OF CERVICAL CANCER PREVENTIVE CARE SERVICES IN THE U.S
Gunjal SS1, Wang X2, Mgbere O3, Essien EJ2
1Precision Health Economics, Austin, TX, USA, 2University of Houston, Houston, TX, USA, 3Houston Department of Health and Human Services, Houston, TX, USA

PHS140
H5
PATIENT RACE/ETHNICITY, PERCEIVED QUALITY OF HEALTHCARE AND HOSPITALIZATIONS: AN INVESTIGATION USING THE MEDICAL EXPENDITURE PANEL SURVEY
Ampaabeng SK1, Onukwugha E2
1IMPAQ International, Columbia, MD, USA, 2University of Maryland School of Pharmacy, Baltimore, MD, USA

PHS141
H6
POINT-OF-CARE, REAL-TIME DECISION SUPPORT TOOLS: A PATHWAY COMPLIANCE SOLUTION BUT ONLY WHEN THEY ARE USED
Feinberg BA1, Laney J2, English S3, Drenning J4
1Cardinal Health, Dublin, OH, USA, 2Cardinal Health, Locust Grove, GA, USA, 3Cardinal Health, Conyers, GA, USA, 4Cardinal Health, Dallas, TX, USA

PHS142
H7
STATUS OF BIRTHS MADE WITHIN SUS IN BRAZIL
Sansone D, Etto H, Andrade TR, Araujo GT, Fonseca M
AxiaBio, São Paulo, Brazil

PHS143
H8
IMPACT OF MEDICATION THERAPY MANAGEMENT (MTM) PILOT PROGRAM ON HEALTHCARE UTILIZATION AND COSTS AMONG TEXAS MEDICAID PATIENTS WITH HYPERTENSION
Makhinova T1, Barner JC1, Lawson KA1, Roberson K2
1The University of Texas at Austin, Austin, TX, USA, 2Texas Pharmacy Association, Austin, TX, USA

PHS144
H9
CHARACTERISTICS OF DRUG THERAPY PROBLEMS AND RESPONSE RATE IN TELEPHONIC COMPREHENSIVE MEDICATION REVIEWS PROVIDED TO 2014 MEDICARE PART D BENEFICIARIES
Wong J
Scott and White Health Plan, Temple, TX, USA

PHS145
H10
IDENTIFYING KEY FACTORS FOR TARGETING PATIENTS MOST SUITABLE FOR COMMUNITY HEALTH WORKER PROGRAM
Wang QC, Nandyala P, Chawla R, Nigam S
Independence Blue Cross, Philadelphia, PA, USA

PHS146
H11
EVALUATION OF A PRE HOSPITAL CARE PROGRAM FOR PATIENTS WITH TRIAGE III-IV
Romero M1, Torres A2, Barrios E3, Villegas J3, Lee J3
1Salutia Foundation, Bogota, Colombia, 2Salutia´s Foundation- Research center in economy, management and health technologies., Bogota, Colombia, 3Coomeva Group, Cali, Colombia

PHS147
H12
IMPACT OF A COMMUNITY PHARMACY-BASED TRANSITION OF CARE PROGRAM ON HOSPITAL READMISSIONS AT 30 AND 180 DAYS
Ni W1, Colayco D2, McCombs J1
1University of Southern California, Los Angeles, CA, USA, 2Komoto Healthcare, Bakersfield, CA, USA

PHS148
WITHDRAWN

PHS149
H13
USE OF PRESCRIPTION MONITORING PROGRAMS BY PRIMARY CARE PHYSICIANS: RESULTS OF A NATIONAL SURVEY
Hwang CS1, Rutkow L2, Turner L2, Lucas E2, Alexander GC3
1Food and Drug Administration, Silver Spring, MD, USA, 2Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, 3Johns Hopkins School of Public Health, Center for Drug Safety and Effectiveness, Baltimore, MD, USA

PHS150
H14
COMPARISON OF GUIDELINES AND MANAGEMENT FOR GASTRIC CANCER SCREENING BETWEEN KOREA AND JAPAN
Hamashima C1, Kim Y2, Choi KS2
1National Cancer Center, Tokyo, Japan, 2National Cancer Control Institute, Gyeonggi-do, South Korea

PHS151
H15
IMPACT OF CASE MANAGEMENT NURSES ON CANCER PATIENTS: A SYSTEMATIC REVIEW
Bregman C1, Doutriaux A2, Cognet M2, Gauthier A2, Pourcel G3, Ferrari C3, Viguier J3
1Amaris, Paris, France, 2Amaris, London, UK, 3Institut National du Cancer, Boulogne Billancourt, France

PHS152
H16
AN INNOVATIVE CLOUD-BASED PLATFORM FOR IMPLEMENTING PERFORMANCE-BASED RISK-SHARING ARRANGEMENTS (PBRSAS) IN ONCOLOGY SETTINGS
De Rosa M1, Martini N2, Ortali M1, Esposito I2, Roncadori A1
1CINECA Interuniversity Consortium, Casalecchio di Reno, Italy, 2Accademia Nazionale di Medicina, Roma, Italy

PHS153
H17
WITHDRAWN

PHS154
H18
ESTIMATING THE HEALTH BENEFITS OF MEETING THE HEALTHY PEOPLE 2020 OBJECTIVES FOR REDUCING INVASIVE COLORECTAL CANCER INCIDENCE IN THE UNITED STATES
Hung M1, Ekwueme D2, Wang J3
1Division of Cancer Prevention and Control, US Centers for Disease Control and Prevention, Chamblee, GA, USA, 2Centers for Disease Control and Prevention, Chamblee, GA, USA, 3National Cheng Kung University College of Medicine, Tainan, Taiwan

PHS155
H19
MORAL HAZARD AND HEALTH INSURANCE: EXAMINING THE ROLE OF PRIVATE VS. PUBLIC INSURANCE IN PROSTATE CANCER SCREENING, PROSTATE CANCER DIAGONOSIS AND PATIENT SATISFACTION WITH PROSTATE CANCER CARE
Zanwar P
University of Houston Clear Lake, Houston, TX, USA

PHS156
H20
HEALTHCARE BURDEN OF CERVICAL CANCER IN A NATIONAL MEDICAID MANAGED CARE POPULATION
Joshi N, Khanna R, Pace P, Banahan III B
University of Mississippi, University, MS, USA

PHS157
H21
WITHDRAWN

PHS158
I1
FACTORS PREDICTING RECEIPT OF PROSTATE SPECIFIC ANTIGEN (PSA) TESTING: EVIDENCE FROM THE NATIONAL AMBULATORY MEDICAL CARE SURVEY (NAMCS) DATA
Haider MR1, Qureshi Z1, Horner R1, Bennett C2
1University of South Carolina, Columbia, SC, USA, 2University of South Carolina College of Pharmacy, Columbia, SC, USA

PHS159
I2
THE BURDEN OF GOUT IN A CANADIAN PRIMARY CARE POPULATION
Williams DM1, Cowan C1, Gendron A1, Goodfield J2, Oraichi D2, Fischer A2, Borrelli R2, Liu N2, Dziarmaga A1
1AstraZeneca Canada Inc., Mississauga, ON, Canada, 2IMS Brogan, Mississauga, ON, Canada

PHS160
I3
EVALUATING THE PREVALENCE OF MENINGITIS IN HAZARA DIVISION, KPK PAKISTAN
Azhar SA, Khan GN, Wazir FW, Izhar IH
COMSATS Institute of Information Technology, Abbottabad, Pakistan

PHS161
I4
RECENT TRENDS IN BACTERIAL INFECTION-RELATED HOSPITALIZATIONS IN THE US
Kurosky SK, Reese ES, Candrilli S
RTI Health Solutions, Research Triangle Park, NC, USA

PHS162
I5
PREVALENCE OF MENTAL HEALTH DISORDERS AND ACCESS TO CARE AMONG CHILDREN ENROLLED IN THE MISSISSIPPI MEDICAID
Nunna S1, Shah R1, Banahan III B1, Hardwick SP2, Clark JP2
1University of Mississippi, University, MS, USA, 2Mississippi Division of Medicaid, Jackson, MS, USA

PHS163
I6
IS THE UPTAKE OF VOLUNTARY MEDICAL MALE CIRCUMCISION INFLUENCED BY LEVEL OF EDUCATION, MARITAL STATUS AND MAIN SOURCE OF INCOME? CASE STUDY OF WESTERN KENYA
Mogere DM
Great Lakes University of Kisumu, Nairobi, Kenya

PHS164
WITHDRAWN

PHS165
I7
IMPACT OF COMMUNITY BASED THERAPY ON CHILDREN WITH MENTAL HEALTH DISORDERS: A HEALTH TECHNOLOGY ASSESSMENT
Chahar A1, Gulati R1, Sharma J1, Likhar N2, Dang A2
1National Health Systems Resource Centre, Division of Healthcare Technology, New Delhi, India, 2MarksMan Healthcare Solutions LLP (HEOR and RWE Consulting), Navi Mumbai, India

PHS166
I8
INCREASING HOUSEHOLDS' ACCESS TO HEALTHCARE; LINKING CLINICIANS TO COMMUNITY HEALTH WORKERS THROUGH COUNTER REFERRAL COMMENTS
Mogere DM, Loum CS, Kaseje D
Great Lakes University of Kisumu, Nairobi, Kenya

PHS167
I9
WITHDRAWN

PHS168
I10
ANTIPSYCHOTIC MEDICATION USE MEASURES FOR CHILDREN AND ADOLESCENTS: METABOLIC SCREENING FOR CHILDREN ON ANTIPSYCHOTICS
Banahan III B1, Nunna S1, Shah R1, Harwick SP2, Clark JP2
1University of Mississippi, University, MS, USA, 2Mississippi Division of Medicaid, Jackson, MS, USA

PHS169
I11
QUALITY AND IMPLEMENTATION BARRIERS OF PREVENTION OF MOTHER TO CHILD TRANSMISSION OF HIV PROGRAM IN ETHIOPIA: A CROSS SECTIONAL STUDY
Legesse B
Karolinska Institutet, Stockholm, Sweden

PHS170
I12
QUALITY OF CARE FOR CHILDHOOD ATTENTION DEFICIT/HYPERACTIVITY DISORDER: A RETROSPECTIVE ANALYSIS OF MISSISSIPPI MEDICAID PROGRAM
Suryavanshi M1, Banahan III B2, Hardwick SP3, Clark JP3
1Univeristy of Mississippii, Oxford, MS, USA, 2University of Mississippi, University, MS, USA, 3Mississippi Division of Medicaid, Jackson, MS, USA

PHS171
I13
DISEASE-SPECIFIC DISTRIBUTION OF HEALTH CARE QUALITY MEASURES IN THE UNITED STATES
Nicholson GL, Halbert RJ
ICON plc, El Segundo, CA, USA

PHS172
I14
WITHDRAWN

PHS173
J1
WITHDRAWN

PHS174
J2
OUTPATIENT FOLLOW-UP VISITS AFTER HOSPITAL DISCHARGE FOR MENTAL ILLNESS AND IMPLICATIONS FOR RE-ADMISSIONS
Lin I1, Muser E2, Munsell M1, Menzin J1
1Boston Health Economics, Inc., Waltham, MA, USA, 2Janssen Scientific Affairs, LLC, Titusville, NJ, USA

PHS175
J3
DECREASING EBM ORDER SET REVIEW AND APPROVAL CYCLE TIME
Castree KL, Cinciripini CL
Hospital Sisters Health System, Belleville, IL, USA

PHS176
J4
PATIENT VALUATION OF DIFFERENT APPROACHES TO MENTAL HEALTH AND SUBSTANCE USE DISORDER TREATMENT
Epstein AJ1, Barry CL2, Fiellin DA3, Busch SH3
1University of Pennsylvania, Philadelphia, PA, USA, 2Johns Hopkins University, Baltimore, MD, USA, 3Yale University, New Haven, CT, USA

PHS177
WITHDRAWN

PHS178
J5
HOSPITAL COST AND QUALITY TRENDS BEFORE AND AFTER ACO ADOPTION
Cutler E1, Henke RE1, Marder WD1, Karaca Z2, Wong H2
1Truven Health Analytics, Cambridge, MA, USA, 2Agency for Healthcare Research and Quality, Rockville, MD, USA

PHS179
J6
READMISSION PATTERNS IN MEDICARE BENEFICIARIES HOSPITALIZED FOR HEART FAILURE
Kilgore M1, Sharma P1, Patel H2, Maya J2, Kielhorn A2
1Univeristy of Alabama at Birmingham, Birmingham, AL, USA, 2Amgen, Thousand Oaks, CA, USA

Contact ISPOR @ info@ispor.org | View Legal Disclaimer
© 2018 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.